Novartis | NVS - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 4.22B 605M 2026-09
Amgen USD 3.86B 1.49B 2026-09
AstraZeneca USD 3.12B 610M 2026-09
Bausch Health Companies USD 436M 178M 2026-09
Biogen USD 97.5M 222M 2026-06
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Canopy Growth CAD -14.58M 142.54M 2026-06
Corcept Therapeutics USD 124.49M 82.35M 2026-09
Drreddys Laboratories INR 9.25B 7.04B 2026-09
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Glaxosmithkline GBP 1.54B 194M 2026-09
J&J USD 210M 5.32B 2026-09
Merck USD 5.07B 6.4B 2026-09
Novartis USD 1.2B 2.06B 2026-09
Novartis USD 1.2B 1.95B 2026-09
Pacira USD 325.3M 320.65M 2026-09
Perrigo USD -27.5M 102M 2026-09
Pfizer USD 3.24B 3.49B 2026-09
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 38.54M 15.39M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 3.02B 2.68B 2026-09
Sanofi EUR 343M 1.27B 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Zoetis USD 591M 100M 2026-09